Skip to Main Content
 
Thought Leadership

340B Drug Pricing Program in 2026

Program Updates, Litigation, and What's Ahead for Safety Net Providers

 
April 7, 2026
12:00 p.m. - 1:00 p.m. CT
Register

Related Industry:

Healthcare 
 
Webinar

Join Husch Blackwell Healthcare attorneys for the second installment of a three-part webinar series that explores key developments affecting safety net providers in 2026. Designed for academic medical centers, public hospitals, health systems, Federally Qualified Health Centers (FQHCs), and rural providers, the series offers timely insights and practical guidance on high impact regulatory and payment trends—all tailored to organizations serving vulnerable communities.

The 340B Drug Pricing Program allows eligible entities to purchase covered outpatient drugs at a substantial discount, providing vital resources to support their safety net missions. The 340B Program has grown into a fundamental pillar of support for the healthcare safety net. This webinar will review the current 340B Program landscape and provide updates on recent developments, including the Health Resources and Services Administration’s latest rebate model pilot plans, notable litigation, manufacturer policy changes, and proposed federal and state legislation. Attendees will gain insight into program requirements, opportunities, and shifts that may be coming.

Presenters
Alexa B. Barton, Attorney
Robert Hess, Attorney
Renee E. Zerbonia, Attorney 

Who Should Attend
Healthcare executives, pharmacy and finance leaders, compliance professionals, and legal counsel for safety net providers.

Continuing Education Credit
This program is pending approval for Arkansas, Colorado, Illinois, Indiana, Iowa, Kansas, Minnesota, Missouri, Nebraska, Ohio, Tennessee, Texas, Utah, and Wisconsin continuing legal education credit.

Questions? Contact Morgan Buciumean at 303.749.7281.

Professionals:

Alexa B. Barton

Senior Associate

Robert Hess

Senior Counsel

Renee E. Zerbonia

Senior Counsel